logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
E

Elizabeth Smyth

Churchill Hospital
H指数:44
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ctDNA predicts radiological response to immune checkpoint inhibition for patients with advanced oesophageal adenocarcinoma: a pilot interventional phase 2 study

循环肿瘤DNA预测免疫检查点抑制剂对晚期食管腺癌患者的影像学反应：一项干预性II期初步研究

Communications Medicine
IF6.3
2026-08-120
OA
Constanza Linossi; Alexander A. Azizi; Andrea Machin; Alimu Dayimu; Nikos Demiris; Helen White; Ahmad Miremadi; Maria O’Donovan; Edmund Godfrey; Paulius D. Mennea; Ze Zhou; Angela An; Richard D. Baird; Elizabeth Smyth; Iris Faull; Simon J. Dovedi; Rebecca C. Fitzgerald; Amit Roshan; Simon Pacey
Antibody-drug conjugates in selected solid tumours: a position statement update based on findings from the third workshop held by the ETOP IBCSG Partners Foundation

抗体药物偶联物在特定实体瘤中的应用：基于ETOP IBCSG Partners基金会第三次研讨会成果的立场声明更新

ESMO Open
IF8.3
2026-07-010
OAAI
Peters, S.; Meyer, M. -l.; Andre, F.; Argiles, G.; Azizi, A. A.; Banerjee, S.; Burgers, S.; Curigliano, G.; Drago, J. Z.; Fontana, E.; Garon, E. B.; Klumper, N.; Le Bescond, L.; Lopez-Rios, F.; Mountzios, G.; Passaro, A.; Paz-Ares, L.; Pistilli, B.; Powles, T.; Reguart, N.; Remon, J.; Schmelzle, T.; Skynner, M. J.; Smit, E.; Smyth, E.; Swanton, C.; Van Cutsem, E.; Loi, S.; Stahel, R. A.
Progression-Free Survival as a surrogate for Overall Survival in gastro-esophageal cancer trials with immunotherapy: a meta-analysis

无进展生存期作为免疫治疗在胃肠癌临床试验中总体生存期的替代指标：一项荟萃分析

European Journal of Cancer
IF7.1
2025-11-290
OAAI
Alberto Giovanni Leone; Fausto Petrelli; Samuel J. Klempner; Elizabeth C. Smyth; Raghav Sundar; Florian Lordick; Sylvie Lorenzen; Micheal Masetti; Radka Obermannova; Maria Alsina; Yelena Y Janjigian; Filippo Pietrantonio
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancreatic cancer

泛亚洲适应性ESMO临床实践指南：胰腺癌患者的诊断、治疗和随访

ESMO Open
IF8.3
2025-10-090
OAAI
D. Tai; T. Conroy; J.J.X. Lee; C.E. Chee; C.-Y. Hao; I. Wijaya; S. Aggarwal; M. Ueno; H.-C. Jeung; N.M. Hashim; J. Tan Chun Bing; L.-T. Chen; K. Korphaisarn; S. Tanasanvimon; W.-C. Chou; E. Cargullo; N.F.A. Muin; M.A. Lee; A. Ohba; S. Bondarde; C.R.A. Lesmana; L. Wang; E.C. Smyth; T. Yoshino; G. Bonney; G. Pentheroudakis; J. Samol; A. Cervantes; E. Poon; M. Ducreux
PD-1/PD-L1 Inhibitors in Advanced, Unresectable Esophageal Squamous-Cell Carcinoma: A Meta-Analysis of Their Effects Across Patient Subgroups

PD-1/PD-L1抑制剂在晚期、不可切除的食管鳞状细胞癌中的应用：一项关于其对不同患者亚组效果的网络分析

critical reviews in oncology hematology
IF0
2025-08-050
PRE
Mohammed S. Beshr; Rana H. Shembesh; Abdelaziz H. Salama; Imane Chenfouh; Sarah M. Alfaqaih; Abdallah Khashan; Arwi Omar Kara; Maram Abuajamieh; Eman Basheer; Zahraa Alla Ansaf; Esraa Arhaym; Mohamedhen Vall Nounou; Mohamed E. Ali; Elizabeth C. Smyth; Muhammed Elhadi; Markus Moehler
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with oncogene-addicted metastatic non-small-cell lung cancer

泛亚适应ESMO临床实践指南，用于癌基因成瘾的转移性非小细胞肺癌患者的诊断，治疗和随访

ESMO OPEN
IF8.3
2024-12-010
PRE
Lee, S. -h.; Menis, J.; Kim, T. M.; Kim, H. R.; Zhou, C.; Kurniawati, S. A.; Prabhash, K.; Hayashi, H.; Lee, D. d. -w.; Imasa, M. S.; Teh, Y. L.; Yang, J. c. -h.; Reungwetwattana, T.; Sriuranpong, V.; Wu, C. -e.; Ang, Y.; Sabando, M.; Thiagarajan, M.; Mizugaki, H.; Noronha, V.; Yulianti, M.; Zhang, L.; Smyth, E.; Yoshino, T.; Park, J. O.; Pentheroudakis, G.; Park, S.; Peters, S.; Ahn, J. B.; Popat, S.
A single arm phase II trial of trastuzumab deruxtecan in patients with gastro-oesophageal adenocarcinoma cancer who are ctDNA and HER2 positive: DECIPHER (TRIALS IN PROGRESS)

在ctDNA和HER2阳性的胃食管腺癌患者中进行曲妥珠单抗deruxtecan的单臂II期试验: 破译 (正在进行的试验)

ANNALS OF ONCOLOGY
IF65.4
2024-06-010
PRE
Smyth, E.; Griffiths, D.; Cozens, K.; Hurt, C.; Waugh, R.; Turkington, R.; Foley, K.; Roy, R.; Sharma, S.; Jurdi, A.; Liu, M. C.; Ngan, S.; Owen, R.; Chuter, D.; Steel, C.; Griffiths, G.

研究方向

暂未获取到该数据
D
David Cunningham
H 指数:153论文数:2,060被引数:13.0万
F
Florian Lordick
H 指数:91论文数:989被引数:4.7万
I
Ian Chau
H 指数:81论文数:850被引数:4.4万
W
William Allum
H 指数:50论文数:299被引数:1.9万
A
Andrés Cervantes
H 指数:99论文数:1,158被引数:6.1万
H
Heike I. Grabsch
H 指数:60论文数:413被引数:1.9万
R
Rebecca C. Fitzgerald
H 指数:100论文数:990被引数:4.4万
K
Kohei Shitara
H 指数:79论文数:1,129被引数:3.5万
H
Hanneke W.M. van Laarhoven
H 指数:72论文数:962被引数:2.4万
R
Radka Obermannová
H 指数:29论文数:121被引数:5,726